This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber...
ME/CFS, which affects millions of Americans, has few dedicated research centers....
Purdue Pharma has submitted its latest opioid lawsuit settlement plan, including...
Mass General Brigham will invest $400 million to create a new cancer institute b...
HHS is weighing plans to drastically cut U.S. government funding for domestic HI...
In the time since the Novartis gene therapy Zolgensma was approved for babies wi...
Health news stories you need to read today.
The FDA has warned Aspen Pharmacare, the largest pharmaceutical company in Afric...
The companies reported Wednesday that batoclimab showed improvements in myasthen...
Why Sutro Biopharma, a company seeking to develop its own cancer drugs, is addin...
Street psychiatrist Liz Frye sees her caregiving work as a kind of apology for t...
“I write on this anniversary to bear witness to the recent but potentially fleet...
The cuts to U.S. foreign aid could result in the resurgence of some diseases. Th...
Pediatricians basically take a “vow of poverty,” but that’s just one reason for ...
Cost isn’t the only barrier to a healthy diet. Taste is, too, writes Marc Siegel...
Prime Medicine and Beam Therapeutics had common origins in gene editing. Now the...
FDA will review nutrients, increase testing for heavy metals and contaminants, e...
The director of public health for the city of Lubbock said Tuesday that uptake o...
In this edition of STAT's Health Tech newsletter: Dr. Oz touting the benefits of...
A little-known HHS agency may face big layoffs, FDA employees return to the offi...
Drugmakers are urging the Trump administration and EU officials to exclude medic...
Sarepta Therapeutics said that a young man died after receiving Elevidys, its ge...
Essential biotech news updates, brought to you by The Readout.